Seres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective trimmed by The Goldman Sachs Group from $1.00 to $0.75 in a report released on Friday,Benzinga reports. The brokerage currently ...

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...

Seres Therapeutics Inc (MCRB) reports reduced net loss and strategic advancements in SER-155, while addressing ongoing ...

Piper Sandler analyst Edward Tenthoff maintained a Hold rating on Seres Therapeutics (MCRB – Research Report) today and set a price target of ...

Ping An P&C can customise compensation plans for losses incurred due to power battery failure in FAW Hongqi’s Hongqi Tiangong ...

Seres Therapeutics (NASDAQ:MCRB – Get Free Report) is projected to release its earnings data before the market opens on ...

Submit to FDA a draft protocol for the next study of SER-155 in allo-HSCT in Q2 2025.; Present SER-155 Phase 1b clinical and exploratory ...

Founder of China's Seres Auto Zhang Xinghai, a delegate to China's top political advisory body, said that competition in China's electric vehicle market is extremely intense on price and technology, ...

In a city like Chicago, where style meets sustainability, and high-end meets down-to-earth, Seres provides the right answer to footwear.

More Chinese electric vehicle companies — including Leapmotor, Li Auto and Seres Group — are starting to turn a profit after burning cash for years in their intense competition for the world ...

Eric Shaff; President, Chief Executive Officer, Director; Seres Therapeutics Inc Lisa von Moltke; Executive Vice President, Chief Medical Officer; Seres Therapeutics Inc Matthew Henn; Executive Vice ...

My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2024 Seres Therapeutics Incorporated Earnings Conference Call. All lines ...